Wednesday, March 05, 2025 | 09:14 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Indoco Remedies' Goa facility receives Establishment Inspection Report from USFDA

Image

Capital Market
Indoco Remedies announced today that it has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for their sterile facility (Plant II) and solid dosages facility (Plant III) at Verna, Goa. The inspection was held from 27 May, 2019 to 4 June, 2019, where the Company had received 4 observations (483s).

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 26 2019 | 4:53 PM IST

Explore News